Table III.
Association between the levels of miR-1 and PIK3CA expression, and clinicopathological characteristics in patients with esophageal squamous cell carcinoma.
| miR-1 expression | PIK3CA expression | |||||
|---|---|---|---|---|---|---|
| Factors | High | Low | P-value | High | Low | P-value |
| Sex | 0.650 | 0.551 | ||||
| Male | 24 | 37 | 29 | 32 | ||
| Female | 6 | 7 | 5 | 8 | ||
| Age, years | 0.255 | 0.801 | ||||
| <60 | 17 | 19 | 16 | 20 | ||
| ≥60 | 13 | 25 | 18 | 20 | ||
| Pathological grading | 0.450 | 0.830 | ||||
| Well-moderately | 17 | 21 | 17 | 21 | ||
| Poorly | 13 | 23 | 17 | 19 | ||
| Invasion depth | 0.080 | 0.653 | ||||
| T1/T2 | 10 | 7 | 7 | 10 | ||
| T3/T4 | 20 | 37 | 27 | 30 | ||
| Lymph node metastasis | <0.001 | 0.006 | ||||
| Positive | 5 | 28 | 21 | 12 | ||
| Negative | 25 | 16 | 13 | 28 | ||
| TNM stage | 0.001 | 0.641 | ||||
| I/II | 22 | 15 | 16 | 21 | ||
| III/IV | 8 | 29 | 18 | 19 | ||
miR, microRNA; PIK3CA, phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit α.